Thus, the identification of the molecular mechanisms that govern EGF-mediated invasion is of critical importance in order to identify novel anti-cancer targets, and this study suggests that preventing anterograde lysosome trafficking is a potentially viable and potent therapeutic target of EGF-driven tumors. Here, EGF is linked to cancer.